International Workshop on
"Translational Research Strategies for Drug Discovery and Clinical Development"
CLIANTHA Research Ltd.
Cliantha Research, full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Tobacco Research, Dermatology, Consumer Research, Research Lab, IVRT, Biometrics, Pharmacovigilance & Medical Services, Environmental Exposure Chambers (EECs). With strategic acquisitions globally, Cliantha has widened the horizon of clinical research & support services for end-to-end developmental needs all across. The company has recently merged its group companies Inflamax Research, Hilltop Research, and Karmic Lifesciences under one flagship brand – Cliantha.
With several advanced clinical sites and bio-analytical laboratories in North America and India, Cliantha now has presence in 4 countries, USA, CANADA, EUROPE and INDIA along with a strong team of 1000+ professionals. Some of the key regulators, such as the USFDA, EMA, AGES, ANSM, AMPS, MCC South Africa, Health Canada, DCGI, CAP, NABL, Turkey MOH, Thailand MoPH and others have successfully inspected Cliantha across the globe. Cliantha Research is headquartered in Ahmedabad and has expanded its domestic reach with 5 regional offices & has presence in Florida & New Jersey in USA & in Mississauga, Winnipeg & Scarborough in Canada & Portugal in Europe.